Both in Biotechnology
Black Diamond Therapeutics vs enGene Therapeutics
Over the past year BDTX returned −52.3% and ENGN returned −75.0%; their daily moves had a correlation of 0.14.
BDTX −52.3% ENGN −75.0%Growth of $1, one year, split-adjusted
| Metric | BDTX | ENGN |
|---|---|---|
| Price | $1.81 | $1.62 |
| Market cap | $104.0M | $108.6M |
| Today | +3.43% | +11.72% |
| 1 month | −6.7% | −13.4% |
| 6 months | −36.9% | −79.5% |
| Year to date | −25.5% | −82.1% |
| 1 year | −53.2% | −77.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $110.5M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 61.5% | 57.4% |
| Short % of float | 11.8% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).